false
0001840563
0001840563
2026-04-08
2026-04-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
April 8, 2026
| PMGC Holdings Inc. |
| (Exact name of registrant as specified in its charter) |
| Nevada |
|
001-41875 |
|
33-2382547 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
c/o 120 Newport Center Drive
Newport Beach, CA |
|
92660 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (888)445-4886
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, $0.0001 par value |
|
ELAB |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01 Regulation FD Disclosure.
On April 8, 2026, PMGC Holdings Inc. (the “Company”)
issued a press release, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K (“Form 8-K”).
The information furnished pursuant to this Item
7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated
by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly
set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
|
Description |
| 99.1 |
|
Press Release dated April 8, 2026. |
| 104 |
|
Cover Page Interactive Data File (formatted in Inline XBRL). |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April
8, 2026
| PMGC Holdings, Inc. |
|
| |
|
|
| By: |
/s/ Graydon Bensler |
|
| Name: |
Graydon Bensler |
|
| Title: |
Chief Executive Officer and Chief Financial Officer |
|
Exhibit 99.1
PMGC Holdings Inc. [NASDAQ: ELAB] PMGC Holdings Fully Utilizes All
Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition Strategy
| ● | Company Maintains Strong Cash Position, Fully Funded for Near-Term Acquisition Pipeline |
| | | |
| ● | Portfolio Spans Aerospace, Defense, Semiconductor, Medical Device, and Data Center Supply Chains |
NEWPORT BEACH, Calif., April 8, 2026 —
PMGC Holdings Inc. (NASDAQ: ELAB) (“the Company,” “PMGC,” “we,” or “our”), a diversified
holding company, today announced that it has utilized all of the $20 million commitment amount under its equity purchase facility (the
“Facility”) with Streeterville Capital, LLC.
History of Strategic Capital Allocation
The Company’s acquisitions over 2025
and Q1 2026 span three precision computer numerical control (“CNC”) manufacturing companies that service large and
medium size companies in the aerospace, defense, medical and industrial sectors, and a specialty IT packaging company that serves over 300 commercial customers across North America’s semiconductor, data center, and IT supply chains:
| ● | Pacific Sun Packaging, Inc. — Acquired in July 2025; focused on custom-engineered protective
packaging for CPUs, memory modules, SSDs, fiber-optic transceivers, and other high-value semiconductor, AI infrastructure, and data center
components; serves over 300 commercial customers across North America’s semiconductor, data center, and IT supply chains. |
| ● | AGA Precision Systems LLC (“AGA”) — Acquired in July 2025; ITAR-registered, AS9100-certified
precision CNC machine shop focused on complex metals, including titanium and Inconel, for aerospace, defense, and industrial customers. |
| ● | Indarg Engineering, Inc. — Acquired in October 2025, under AGA; a bolt-on asset acquisition
which expands AGA’s machining capacity to support growing demand from aerospace, space, and industrial customers. |
| ● | SVM Machining, Inc. — Acquired in February 2026; a precision CNC manufacturing company serving
medical device and surgical robotics, aerospace including satellite, spaceflight, and unmanned aerial vehicle (UAV) components, biotech
and pharmaceutical lab automation, semiconductor wafer handling, and transportation customers. |
Management believes these acquisitions strengthen
PMGC’s position in sectors where reliability, technical certification, and high switching costs support long-term customer retention
and value creation.
Near-Term Priorities
Looking ahead, PMGC intends to pursue both organic
growth and selective acquisitions that expand operational scale and deepen its presence in markets with favorable long-term fundamentals.
The Company’s near-term priorities include:
| ● | Organic growth, integration, and margin improvement across its precision manufacturing and specialty packaging
subsidiaries; |
| ● | Selective, accretive acquisitions in aerospace, defense, and adjacent vertical markets that expand operational
scale; |
| ● | Continued advancement of Northstrive Biosciences Inc.’s multi-asset biopharmaceutical pipeline focused
on muscle preservation and obesity in the context of GLP-1 receptor agonist weight loss therapies, including EL-22’s FDA-supported
path toward a Phase 2 IND submission; and |
| ● | Evaluation of M&A capital structures and accretive financing alternatives designed to support the
Company’s next phase of growth. |
PMGC remains focused on allocating capital into
assets capable of generating sustainable cash flow, long-term compounding, and shareholder value creation.
About PMGC Holdings Inc.
PMGC Holdings Inc. is a diversified holding company
that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. We are committed
to exploring opportunities in multiple sectors to maximize growth and value. For more information, please visit https://www.pmgcholdings.com.
Forward-Looking Statements
Statements contained in this press release regarding
matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation
Reform Act of 1995, as amended. Words such as “believes,” “expects,” “plans,” “potential,”
“would” and “future” or similar expressions such as “look forward” are intended to identify forward-looking
statements. Forward-looking statements are made as of the date of this press release and are neither historical facts nor assurances of
future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business,
future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations
and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks
and changes in circumstances that are difficult to predict and many of which are outside of our control. Although the Company believes
that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn
out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Therefore,
you should not rely on any of these forward-looking statements. These and other risks are described more fully in PMGC’s filings
with the United States Securities and Exchange Commission (“SEC”), including the “Risk Factors” section of the
Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026, and its other documents
subsequently filed with or furnished to the SEC. Investors and security holders are urged to read these documents free of charge on the
SEC’s web site at www.sec.gov. All forward-looking statements contained in this press release speak only as of the date on which
they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events
that occur or circumstances that exist after the date on which they were made.
IR Contact: IR@pmgcholdings.com
